Need help finding what you are looking for?
Contact Us
PUBLISHER: IMARC | PRODUCT CODE: 1207154
PUBLISHER: IMARC | PRODUCT CODE: 1207154
Amyotrophic Lateral Sclerosis Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028
PUBLISHED:
PAGES: 142 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
The global amyotrophic lateral sclerosis treatment market size reached US$ 719.2 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 969.3 Million by 2028, exhibiting a growth rate (CAGR) of 4.9% during 2023-2028.
Amyotrophic Lateral Sclerosis (ALS) Treatment refers to a degenerative disease that affects the nerve cells in the spinal cord and brain, resulting in loss of muscle control. It primarily occurs due to gene mutation, disorganized immune response, chemical imbalance, etc. Some of the common symptoms of ALS include muscle stiffness, twitching of the muscles, weakness in the legs or arms, cognitive and behavioral changes, trouble in swallowing, slurred speech, etc. The diagnosis of ALS relies on medical history, physical examination, electrodiagnostic testing, and neuroimaging.
Amyotrophic Lateral Sclerosis Treatment Market Trends:
- The rising incidences of neurodegenerative disorders due to changing lifestyle patterns and hectic schedules of the individuals are primarily driving the Amyotrophic Lateral Sclerosis Treatment treatment market. Besides this, the expanding geriatric population, who are more susceptible to such neurological ailments, is also augmenting the market growth. Furthermore, several NGOs and private organizations are undertaking numerous initiatives to increase awareness regarding the diagnosis and treatment of ALS among the masses. This, in turn, is creating a positive outlook for the market. Additionally, the growing penetration of targeted and symptomatic treatment options for ALS is acting as a significant growth-inducing factor. Moreover, the elevating focus on clinical trials and faster approval of oral drugs for ALS treatment is also bolstering the market growth. Moreover, the increasing strategic collaborations among various research institutes to develop innovative treatment procedures that aim at enhancing muscle function, immune modulation, and neuroprotection are further catalyzing the global market. In the coming years, the continuous upgradation of healthcare infrastructures along with elevating penetration of refurbishment policies will continue to drive the global amyotrophic lateral sclerosis (ALS) treatment market.
Key Market Segmentation:
- IMARC Group provides an analysis of the key trends in each sub-segment of the global amyotrophic lateral sclerosis treatment market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on ALS type, drug type, diagnosis type, treatment and distribution channel.
Breakup by ALS Type:
- Sporadic ALS
- Familial ALS
Breakup by Drug Type:
- Marketed Drugs
- Emerging Drugs
Breakup by Diagnosis Type:
- Electromyogram
- MRI
- Blood and Urine Tests
- Spinal Tap
- Muscle Biopsy
Breakup by Treatment:
- Medication
- Stem Cell Therapy
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
- The competitive landscape of the industry has also been examined along with the profiles of the key players being AB Science, Ascend Pharmaceuticals LLC, BrainStorm Cell Therapeutics Inc., Corestem Inc., Cytokinetics Inc., Eledon Pharmaceuticals Inc., Ionis Pharmaceuticals Inc., ITF Pharma (Italfarmaco S.p.A), Mitsubishi Chemical Group Corpotion, Revalesio Corporation and Treeway B.V.
Key Questions Answered in This Report:
- How has the global amyotrophic lateral sclerosis treatment market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global amyotrophic lateral sclerosis treatment market?
- What are the key regional markets?
- What is the breakup of the market based on the ALS type?
- What is the breakup of the market based on the drug type?
- What is the breakup of the market based on the diagnosis type?
- What is the breakup of the market based on the treatment?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global amyotrophic lateral sclerosis treatment market and who are the key players?
- What is the degree of competition in the industry?
Product Code: SR1323A626_Report
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Amyotrophic Lateral Sclerosis Treatment Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by ALS Type
- 6.1 Sporadic ALS
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Familial ALS
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Drug Type
- 7.1 Marketed Drugs
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Emerging Drugs
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Diagnosis Type
- 8.1 Electromyogram
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 MRI
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Blood and Urine Tests
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Spinal Tap
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Muscle Biopsy
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Treatment
- 9.1 Medication
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Stem Cell Therapy
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Others
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
10 Market Breakup by Distribution Channel
- 10.1 Hospital Pharmacies
- 10.1.1 Market Trends
- 10.1.2 Market Forecast
- 10.2 Retail Pharmacies
- 10.2.1 Market Trends
- 10.2.2 Market Forecast
- 10.3 Others
- 10.3.1 Market Trends
- 10.3.2 Market Forecast
11 Market Breakup by Region
- 11.1 North America
- 11.1.1 United States
- 11.1.1.1 Market Trends
- 11.1.1.2 Market Forecast
- 11.1.2 Canada
- 11.1.2.1 Market Trends
- 11.1.2.2 Market Forecast
- 11.1.1 United States
- 11.2 Asia-Pacific
- 11.2.1 China
- 11.2.1.1 Market Trends
- 11.2.1.2 Market Forecast
- 11.2.2 Japan
- 11.2.2.1 Market Trends
- 11.2.2.2 Market Forecast
- 11.2.3 India
- 11.2.3.1 Market Trends
- 11.2.3.2 Market Forecast
- 11.2.4 South Korea
- 11.2.4.1 Market Trends
- 11.2.4.2 Market Forecast
- 11.2.5 Australia
- 11.2.5.1 Market Trends
- 11.2.5.2 Market Forecast
- 11.2.6 Indonesia
- 11.2.6.1 Market Trends
- 11.2.6.2 Market Forecast
- 11.2.7 Others
- 11.2.7.1 Market Trends
- 11.2.7.2 Market Forecast
- 11.2.1 China
- 11.3 Europe
- 11.3.1 Germany
- 11.3.1.1 Market Trends
- 11.3.1.2 Market Forecast
- 11.3.2 France
- 11.3.2.1 Market Trends
- 11.3.2.2 Market Forecast
- 11.3.3 United Kingdom
- 11.3.3.1 Market Trends
- 11.3.3.2 Market Forecast
- 11.3.4 Italy
- 11.3.4.1 Market Trends
- 11.3.4.2 Market Forecast
- 11.3.5 Spain
- 11.3.5.1 Market Trends
- 11.3.5.2 Market Forecast
- 11.3.6 Russia
- 11.3.6.1 Market Trends
- 11.3.6.2 Market Forecast
- 11.3.7 Others
- 11.3.7.1 Market Trends
- 11.3.7.2 Market Forecast
- 11.3.1 Germany
- 11.4 Latin America
- 11.4.1 Brazil
- 11.4.1.1 Market Trends
- 11.4.1.2 Market Forecast
- 11.4.2 Mexico
- 11.4.2.1 Market Trends
- 11.4.2.2 Market Forecast
- 11.4.3 Others
- 11.4.3.1 Market Trends
- 11.4.3.2 Market Forecast
- 11.4.1 Brazil
- 11.5 Middle East and Africa
- 11.5.1 Market Trends
- 11.5.2 Market Breakup by Country
- 11.5.3 Market Forecast
12 SWOT Analysis
- 12.1 Overview
- 12.2 Strengths
- 12.3 Weaknesses
- 12.4 Opportunities
- 12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
- 14.1 Overview
- 14.2 Bargaining Power of Buyers
- 14.3 Bargaining Power of Suppliers
- 14.4 Degree of Competition
- 14.5 Threat of New Entrants
- 14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
- 16.1 Market Structure
- 16.2 Key Players
- 16.3 Profiles of Key Players
- 16.3.1 AB Science
- 16.3.1.1 Company Overview
- 16.3.1.2 Product Portfolio
- 16.3.1.3 Financials
- 16.3.1.4 SWOT Analysis
- 16.3.2 Ascend Pharmaceuticals LLC
- 16.3.2.1 Company Overview
- 16.3.2.2 Product Portfolio
- 16.3.3 BrainStorm Cell Therapeutics Inc.
- 16.3.3.1 Company Overview
- 16.3.3.2 Product Portfolio
- 16.3.4 Corestem Inc.
- 16.3.4.1 Company Overview
- 16.3.4.2 Product Portfolio
- 16.3.4.3 Financials
- 16.3.5 Cytokinetics Inc.
- 16.3.5.1 Company Overview
- 16.3.5.2 Product Portfolio
- 16.3.5.3 Financials
- 16.3.5.4 SWOT Analysis
- 16.3.6 Eledon Pharmaceuticals Inc.
- 16.3.6.1 Company Overview
- 16.3.6.2 Product Portfolio
- 16.3.6.3 Financials
- 16.3.7 Ionis Pharmaceuticals Inc.
- 16.3.7.1 Company Overview
- 16.3.7.2 Product Portfolio
- 16.3.7.3 Financials
- 16.3.7.4 SWOT Analysis
- 16.3.8 ITF Pharma (Italfarmaco S.p.A)
- 16.3.8.1 Company Overview
- 16.3.8.2 Product Portfolio
- 16.3.9 Mitsubishi Chemical Group Corpotion
- 16.3.9.1 Company Overview
- 16.3.9.2 Product Portfolio
- 16.3.9.3 Financials
- 16.3.9.4 SWOT Analysis
- 16.3.10 Revalesio Corporation
- 16.3.10.1 Company Overview
- 16.3.10.2 Product Portfolio
- 16.3.11 Treeway B.V.
- 16.3.11.1 Company Overview
- 16.3.11.2 Product Portfolio
- 16.3.1 AB Science
Product Code: SR1323A626_Report
List of Figures
- Figure 1: Global: Amyotrophic Lateral Sclerosis Treatment Market: Major Drivers and Challenges
- Figure 2: Global: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017-2022
- Figure 3: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 4: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by ALS Type (in %), 2022
- Figure 5: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Drug Type (in %), 2022
- Figure 6: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Diagnosis Type (in %), 2022
- Figure 7: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Treatment (in %), 2022
- Figure 8: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Distribution Channel (in %), 2022
- Figure 9: Global: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Region (in %), 2022
- Figure 10: Global: Amyotrophic Lateral Sclerosis Treatment (Sporadic ALS) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 11: Global: Amyotrophic Lateral Sclerosis Treatment (Sporadic ALS) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 12: Global: Amyotrophic Lateral Sclerosis Treatment (Familial ALS) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 13: Global: Amyotrophic Lateral Sclerosis Treatment (Familial ALS) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 14: Global: Amyotrophic Lateral Sclerosis Treatment (Marketed Drugs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 15: Global: Amyotrophic Lateral Sclerosis Treatment (Marketed Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 16: Global: Amyotrophic Lateral Sclerosis Treatment (Emerging Drugs) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 17: Global: Amyotrophic Lateral Sclerosis Treatment (Emerging Drugs) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 18: Global: Amyotrophic Lateral Sclerosis Treatment (Electromyogram) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 19: Global: Amyotrophic Lateral Sclerosis Treatment (Electromyogram) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 20: Global: Amyotrophic Lateral Sclerosis Treatment (MRI) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 21: Global: Amyotrophic Lateral Sclerosis Treatment (MRI) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 22: Global: Amyotrophic Lateral Sclerosis Treatment (Blood and Urine Tests) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 23: Global: Amyotrophic Lateral Sclerosis Treatment (Blood and Urine Tests) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 24: Global: Amyotrophic Lateral Sclerosis Treatment (Spinal Tap) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 25: Global: Amyotrophic Lateral Sclerosis Treatment (Spinal Tap) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 26: Global: Amyotrophic Lateral Sclerosis Treatment (Muscle Biopsy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 27: Global: Amyotrophic Lateral Sclerosis Treatment (Muscle Biopsy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 28: Global: Amyotrophic Lateral Sclerosis Treatment (Medication) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 29: Global: Amyotrophic Lateral Sclerosis Treatment (Medication) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 30: Global: Amyotrophic Lateral Sclerosis Treatment (Stem Cell Therapy) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 31: Global: Amyotrophic Lateral Sclerosis Treatment (Stem Cell Therapy) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 32: Global: Amyotrophic Lateral Sclerosis Treatment (Other Treatments) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 33: Global: Amyotrophic Lateral Sclerosis Treatment (Other Treatments) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 34: Global: Amyotrophic Lateral Sclerosis Treatment (Hospital Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 35: Global: Amyotrophic Lateral Sclerosis Treatment (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 36: Global: Amyotrophic Lateral Sclerosis Treatment (Retail Pharmacies) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 37: Global: Amyotrophic Lateral Sclerosis Treatment (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 38: Global: Amyotrophic Lateral Sclerosis Treatment (Other Distribution Channels) Market: Sales Value (in Million US$), 2017 & 2022
- Figure 39: Global: Amyotrophic Lateral Sclerosis Treatment (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 40: North America: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 41: North America: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 42: United States: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 43: United States: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 44: Canada: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 45: Canada: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 46: Asia-Pacific: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 47: Asia-Pacific: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 48: China: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 49: China: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 50: Japan: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 51: Japan: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 52: India: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 53: India: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 54: South Korea: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 55: South Korea: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 56: Australia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 57: Australia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 58: Indonesia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 59: Indonesia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 60: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 61: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 62: Europe: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 63: Europe: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 64: Germany: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 65: Germany: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 66: France: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 67: France: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 68: United Kingdom: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 69: United Kingdom: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 70: Italy: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 71: Italy: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 72: Spain: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 73: Spain: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 74: Russia: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 75: Russia: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 76: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 77: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 78: Latin America: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 79: Latin America: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 80: Brazil: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 81: Brazil: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 82: Mexico: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 83: Mexico: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 84: Others: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 85: Others: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 86: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market: Sales Value (in Million US$), 2017 & 2022
- Figure 87: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market: Breakup by Country (in %), 2022
- Figure 88: Middle East and Africa: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Sales Value (in Million US$), 2023-2028
- Figure 89: Global: Amyotrophic Lateral Sclerosis Treatment Industry: SWOT Analysis
- Figure 90: Global: Amyotrophic Lateral Sclerosis Treatment Industry: Value Chain Analysis
- Figure 91: Global: Amyotrophic Lateral Sclerosis Treatment Industry: Porter's Five Forces Analysis
List of Tables
- Table 1: Global: Amyotrophic Lateral Sclerosis Treatment Market: Key Industry Highlights, 2022 and 2028
- Table 2: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by ALS Type (in Million US$), 2023-2028
- Table 3: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Drug Type (in Million US$), 2023-2028
- Table 4: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Diagnosis Type (in Million US$), 2023-2028
- Table 5: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Treatment (in Million US$), 2023-2028
- Table 6: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Distribution Channel (in Million US$), 2023-2028
- Table 7: Global: Amyotrophic Lateral Sclerosis Treatment Market Forecast: Breakup by Region (in Million US$), 2023-2028
- Table 8: Global: Amyotrophic Lateral Sclerosis Treatment Market: Competitive Structure
- Table 9: Global: Amyotrophic Lateral Sclerosis Treatment Market: Key Players
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.